There's No Escaping Pharming Group N.V.'s (AMS:PHARM) Muted Revenues Despite A 29% Share Price Rise
May 10
Have your own idea? Try our Stock Screener
Dutch (AEX) Biotech Industry Analysis
UpdatedMay 18, 2025
DataAggregated Company Financials
Companies3
- 7D3.6%
- 3M-1.3%
- 1Y-7.2%
- YTD-11.3%
Over the last 7 days, the Biotech industry has risen 4.4%, driven by gains from Galapagos of 6.0%. Meanwhile, Pharming Group actually underperformed within the industry, shrinking 6.6% in the last week. In contrast, the industry has lost 8.3% in the last 12 months. As for the next few years, earnings are expected to grow by 36% per annum.
Industry Valuation and Performance
Has the Dutch Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 19 May 2025 | €2.2b | €575.8m | -€212,563,052.80 | n/a | -10.5x | 3.9x |
| Wed, 16 Apr 2025 | €1.9b | €539.0m | -€11,774,310.10 | n/a | -160.2x | 3.5x |
| Fri, 14 Mar 2025 | €2.1b | €549.5m | -€11,442,277.80 | n/a | -186.7x | 3.9x |
| Sun, 09 Feb 2025 | €2.0b | €536.8m | -€77,867,228.60 | n/a | -25.9x | 3.8x |
| Tue, 07 Jan 2025 | €2.4b | €535.0m | -€77,754,943.70 | n/a | -31.2x | 4.5x |
| Thu, 05 Dec 2024 | €2.2b | €531.7m | -€77,549,979.20 | n/a | -28.3x | 4.1x |
| Sat, 02 Nov 2024 | €2.2b | €523.8m | -€77,058,064.40 | n/a | -28x | 4.1x |
| Mon, 30 Sep 2024 | €2.3b | €510.0m | €19.6m | 55.2x | 115.9x | 4.4x |
| Wed, 28 Aug 2024 | €2.2b | €509.6m | €19.6m | 54.9x | 112.6x | 4.3x |
| Fri, 26 Jul 2024 | €2.2b | €481.8m | €20.8m | 54.1x | 105.1x | 4.5x |
| Sun, 23 Jun 2024 | €2.1b | €485.2m | €20.6m | 51.7x | 101.3x | 4.3x |
| Tue, 21 May 2024 | €2.3b | €481.5m | €20.8m | 57.9x | 112.6x | 4.9x |
| Thu, 18 Apr 2024 | €2.5b | €469.6m | -€40,162,585.60 | n/a | -61.3x | 5.2x |
| Sat, 16 Mar 2024 | €2.8b | €465.0m | -€39,571,301.50 | n/a | -70.2x | 6x |
| Mon, 12 Feb 2024 | €3.4b | €746.7m | -€199,805,190.50 | n/a | -17.1x | 4.6x |
| Wed, 10 Jan 2024 | €3.5b | €744.0m | -€199,531,709.00 | n/a | -17.8x | 4.8x |
| Fri, 08 Dec 2023 | €3.3b | €746.6m | -€199,791,958.00 | n/a | -16.6x | 4.5x |
| Sun, 05 Nov 2023 | €3.3b | €747.9m | -€199,926,493.00 | n/a | -16.4x | 4.4x |
| Tue, 03 Oct 2023 | €3.2b | €756.6m | -€199,272,145.00 | n/a | -16.2x | 4.3x |
| Thu, 31 Aug 2023 | €3.4b | €749.0m | -€200,530,037.00 | n/a | -16.9x | 4.5x |
| Sat, 29 Jul 2023 | €3.5b | €730.5m | -€211,438,069.00 | n/a | -16.7x | 4.8x |
| Mon, 26 Jun 2023 | €3.5b | €732.8m | -€211,461,610.00 | n/a | -16.3x | 4.7x |
| Wed, 24 May 2023 | €3.9b | €734.8m | -€211,481,161.00 | n/a | -18.3x | 5.3x |
| Fri, 21 Apr 2023 | €3.2b | €692.7m | -€233,685,884.00 | 51.2x | -13.7x | 4.6x |
| Sun, 19 Mar 2023 | €3.4b | €708.9m | -€218,735,890.00 | 46.9x | -15.3x | 4.7x |
| Tue, 14 Feb 2023 | €3.6b | €778.1m | €20.3m | 236.2x | 177.7x | 4.6x |
| Thu, 12 Jan 2023 | €3.9b | €777.5m | €20.2m | 267.9x | 192.8x | 5x |
| Sat, 10 Dec 2022 | €3.3b | €781.3m | €20.8m | 223.2x | 160.3x | 4.3x |
| Mon, 07 Nov 2022 | €3.7b | €793.6m | €22.6m | 265.7x | 165.4x | 4.7x |
| Wed, 05 Oct 2022 | €3.9b | €719.0m | -€73,250,120.00 | 34.3x | -53x | 5.4x |
| Fri, 02 Sep 2022 | €4.2b | €719.6m | -€72,279,749.00 | 36.5x | -57.7x | 5.8x |
| Sun, 31 Jul 2022 | €3.9b | €716.0m | -€127,837,306.00 | 46.4x | -30.7x | 5.5x |
| Tue, 28 Jun 2022 | €4.2b | €708.4m | -€128,251,705.00 | 48.2x | -32.5x | 5.9x |
| Thu, 26 May 2022 | €4.0b | €707.2m | -€128,317,309.00 | 48.4x | -31.5x | 5.7x |
Price to Earnings Ratio
-31.5x
Current Industry PE
- There are only 3 companies in the Dutch Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 6.7% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Dutch Healthcare industry?
| NL Market | 3.55% | |
| Healthcare | -0.94% | |
| Biotech | 3.57% | |
| Biotech | 3.57% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GLPG Galapagos | €24.40 | 7.4% +€110.7m | -11.3% | PS5.6x |